Genetic testing Clause Samples

Genetic testing. The insured person is not covered for the cost of genetic tests, when those tests are undertaken to establish whether or not the insured person may be genetically disposed to the development of a medical condition.

Genetic testing. We will not use, require or request a genetic test, the results of a genetic test, genetic information or genetic Services for the purpose of rejecting, limiting, canceling or refusing to renew a health insurance policy or contract. Additionally, genetic information or the request for such information will not be used to increase the rates or affect the terms or conditions of, or otherwise affect the coverage of a Member. We will not release identifiable genetic information or the results of a genetic test without prior written authorization from the Member from whom the test results or genetic information was obtained to:

Genetic testing. (Please refer to the Benefit Schedule for other benefit provisions which may apply.)

Genetic testing. The Plan attests that it does not limit genetic testing when Medically Necessary, use information obtained from genetic testing to limit coverage, adjust premiums based upon genetic information, request or require genetic testing or collect genetic information from an individual at any time for underwriting purposes.

Genetic testing. Genetic testing will be performed at the Screen A Visit to confirm eligibility. Patients with definitive diagnosis of Alport syndrome from previous genetic testing will not have genetic testing performed as part of the study, but must provide documentation of genetic diagnosis for eligibility. Patients without definitive genetic diagnosis of Alport must provide documentation of histopathological diagnosis, as assessed by electron microscopy, for eligibility. Detailed instructions on collection, storage and shipment of the blood sample required for genetic testing will be provided in a separate laboratory manual provided to the investigator.

Genetic testing. Forward works with a third-party genetic testing company to make available certain genetic testing for you. To participate in such genetic testing, you will be required to sign a separate Informed Consent for Genetic Testing (“Genetic Testing Consent”). If you sign a Genetic Testing Consent, the Genetic Testing Consent will be considered part of this Agreement and the terms and conditions of this Agreement, including the disclaimers, limitations of liability and binding arbitration/class waiver, will apply to any genetic testing performed for you.

Genetic testing. Where consent is given, an optional genetic sample for biomarker testing will be collected at the Screening visit. The objective of this research is to collect and store blood samples for possible DNA extraction and exploratory research into how genes or specific genetic variation may influence response (ie, distribution, safety, tolerability, and efficacy) to SAGE-217. Specific genetic variations of interest include but are not limited to: classes of metabolizing enzymes (eg, cytochrome P450 supra-family genes), genes encoding enzymes involved in the production and metabolism of SAGE-217 (eg, AKR1C4 [3α-hydroxysteroid dehydrogenase]), genes associated with the GABA receptor (eg, GABRA1-A6, GABRB1-B3, GABRD, GABRE, GABRG1-3), and genes associated with the production and degradation of GABA. Future research may suggest other genes or gene categories as candidates for influencing not only response to SAGE-217 but also susceptibility to disorders for which SAGE-217 may be evaluated. Thus, the genetic research may involve study of additional unnamed genes or gene categories, but only as related to disease susceptibility and drug action.

Genetic testing. Genetic testing and counseling are considered medically necessary when criteria are met as specified in AMPM Policy 310-II.